Asian Journal Of Social Pharmacy

Abstract: Objective To provide reference for the development strategy of China’s enterprises under the current policy background of generic drug consistency evaluation and volume procurement. Methods China’s current policies on generic drugs and market environment were analyzed and the development paths of international top pharmaceutical enterprises were studied as well. Results and Conclusion There are four transformation and upgrading paths for China’s pharmaceutical enterprises. First, they should invest more in innovation to realize the globalization of new drugs. Second, overseas patented new drugs should be introduced actively. Third, they must focus on the research and development of high-end generic drugs. Lastly, the transformation from active pharmaceutical ingredients into pharmaceutic preparation should be carried out quickly. Under the background of volume procurement, the pharmaceutical market pattern will be completely changed. The research and development capability and patented drugs will become the core competitive advantages of enterprises.

Key words: volume procurement, generic drug, pharmaceutical enterprise